First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 29.81 CNY +0.54%
Updated: May 31, 2023

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on May 30, 2023.

Estimated DCF Value of one 600993 stock is 29.72 CNY. Compared to the current market price of 29.81 CNY, the stock is Fairly Valued.

DCF Value
Base Case
29.72 CNY
Fairly Valued
DCF Value
Price
M
Worst Case
Base Case
Best Case
29.72
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 29.72 CNY
Mayinglong Pharmaceutical Group Co Ltd Competitors:
DCF Valuation
OCUL
Ocular Therapeutix Inc
ROVI
Laboratorios Farmaceuticos ROVI SA
002826
Tibet Aim Pharm Inc
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
688356
Jenkem Technology Co Ltd
PRVB
Provention Bio Inc
CAMX
Camurus AB
002550
Changzhou Qianhong Biopharma Co Ltd

Present Value Calculation

The first step in the DCF calculation process is to estimate the company's future free cash flow. Once free cash flow is forecasted, it is discounted at a risk-appropriate discount rate. The resulting value is the present value of the company's free cash flow. You can change any model inputs below.

Available Valuation Models
1 valuation model available
Alpha Spread
Updated on May 30, 2023
Default Valuation
Create My Valuation Model
Other investors haven't shared any valuation models for Mayinglong Pharmaceutical Group Co Ltd.
Model Settings
Discount Rate
7.06%
Forecast Period
5 Years
Terminal Growth
0%
Discount Rate
7.06%
Terminal Growth
0%
Growth Period
5 Years
Copy as My Model

DCF Model
Base Case Scenario

Rotate your device to view
DCF Model

To view the process of deriving the DCF Value of one share from the estimated Present Value, see the DCF Value Calculation block.

DCF Value Calculation

Depending on which type of operating model is chosen (equity or whole firm valuation model), the resulting value is either the value of equity or the value of the entire firm. In the case of the latter, to move from the value of the firm to the value of equity, liabilities are subtracted and assets are added.

Capital Structure
From Present Value to DCF Value

Present Value 12.8B CNY
Equity Value 12.8B CNY
/ Shares Outstanding 431M
600993 DCF Value 29.72 CNY
Fairly Valued

To view the process of calculating the Present Value of Mayinglong Pharmaceutical Group Co Ltd' future free cash flow, see the Present Value Calculation block.

Valuation Analysis

After the valuation process, in order to gain a deeper understanding of the relationship between risk and opportunity, it is useful to study the dynamic of company's valuation under various inputs to the DCF model in use.

DCF Financials
Financials used in DCF Calculation

Revenue
5.5B 8.8B
Net Income
716M 1.1B
FCFE
640M 961M

Sensitivity Analysis
DCF Value Sensitivity Analysis

See Also

Similar Stocks
What is the DCF value of one 600993 stock?

Estimated DCF Value of one 600993 stock is 29.72 CNY. Compared to the current market price of 29.81 CNY, the stock is Fairly Valued.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Using the DCF Operating Model we project Mayinglong Pharmaceutical Group Co Ltd's future free cash flow and discount it at a selected discount rate to calculate its Present Value (12.8B CNY).

2. DCF Value Calculation. We use the company's capital structure to calculate the total Equity Value based on the previously computed Present Value of the free cash flow. Dividing the Equity Value by the number of shares outstanding gives us the DCF Value of 29.72 CNY per one 600993 share.